CD274 and cancer: Recent years have enabled a rapid expansion of the current knowledge regarding PD-1 immunology, which involves cancer immunity, autoimmunity, infection immunity, transplantation immunity, allergy, immune privilege, and PD-1/PD-L1 inhibitor-related irAEs.